| Literature DB >> 30963593 |
Shaghayegh Tajik1, Mohsen Badalzadeh1,2, Mohammad Reza Fazlollahi1, Massoud Houshmand3, Nasrin Bazargan4, Masoud Movahedi5, Maryam Mahlouji Rad1, Seyed Alireza Mahdaviani6, Setareh Mamishi7, Ghamar Taj Khotaei7, Davood Mansouri8, Fariborz Zandieh9, Zahra Pourpak1.
Abstract
One of the components of NADPH oxidase is p47-phox, encoded by NCF1 gene. This study aims to find new genetic changes and clinical features in 38 Iranian patients with autosomal recessive chronic granulomatous disease (AR-CGD) caused by NCF1 gene defect. Patients who had abnormal NBT and DHR-1,2,3 assay with loss of p47-phox in Western blotting were included in this study. After recording demographic and clinical data, PCR amplification was performed followed by direct sequencing for all exons and exon-intron boundaries. The most common form of CGD in Iran was AR-CGD due to consanguinity marriages. Among patients with AR-CGD, NCF1 deficiency was found to be more common than other forms. Cutaneous involvements (53%), pulmonary infections (50%) and lymphadenopathy (29%) were more prevalent than other clinical manifestations of CGD. Mutation analysis of NCF1 gene identified five different mutations. Homozygous delta GT deletion (c.75_76delGT) was the most frequent mutation and was detected in more than 63% of families. Six families had a nonsense mutation in exon 7 (c.579G > A). Two novel mutations were found in exon 4 in two families, including a missense mutation (c.328C > T) and a nine-nucleotide deletion (c.331_339delTGTCCCCAC). Genetic detection of these mutations may result in early diagnosis and prevention of possible complications of the disease. This could be useful for timely decision-making for haematopoietic stem cell transplantation and for carrier detection as well as prenatal diagnosis of next children in the affected families. Our findings might help to predict outcomes, raise awareness and help effective treatment in these patients.Entities:
Keywords: NADPH oxidase; NCF1 gene; chronic granulomatous disease; mutation; novel; p47-phox
Mesh:
Substances:
Year: 2019 PMID: 30963593 DOI: 10.1111/sji.12767
Source DB: PubMed Journal: Scand J Immunol ISSN: 0300-9475 Impact factor: 3.487